Alterations in UBE2O expression were observed in various types of cancer, including prostate cancer, breast cancer, and head and neck squamous carcinoma, suggesting that UBE2O may be an oncogene [55,56,57]. The gene discussed is UBE2O; the disease is Familial prostate cancer.